V. Michael Holers

About

Dr. Holers is the Scoville Professor of Rheumatology at the University of Colorado School of Medicine. He has also been Rheumatology Division Head since 2000 and charged with overseeing the medical and scientific educational, as well as research, activities of that highly acclaimed group. Dr. Holers has a long history of academic leadership in the field of Rheumatology, and he is currently a member of the American College of Rheumatology Board of Directors. In addition, Dr. Holers was a co-founder of Taligen Therapeutics, a biotechnology company that developed novel anti-inflammatory therapeutics and was acquired by Alexion Pharmaceuticals in 2011.

Investment Focus

Location

Aurora, US